Showing 1 - 6 results of 6 for search 'Laura B Martin', query time: 0.02s Refine Results
  1. 1
    Characterization of Citrobacter sp. line 328 as a source of Vi for a Vi-CRM197 glycoconjugate vaccine against Salmonella Typhi

    Characterization of Citrobacter sp. line 328 as a source of Vi for a Vi-CRM197 glycoconjugate vaccine against Salmonella Typhi by Simona Rondini, Francesca Micoli, Luisa Lanzilao, Ivan Pisoni, Vito Di Cioccio, Allan J Saul, Laura B Martin

    Published 2012-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults.

    Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults. by Ruth D Ellis, Laura B Martin, Donna Shaffer, Carole A Long, Kazutoyo Miura, Michael P Fay, David L Narum, Daming Zhu, Gregory E D Mullen, Siddhartha Mahanty, Louis H Miller, Anna P Durbin

    Published 2010-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009

    Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009 by Audino Podda, Allan James Saul, Rashmi Arora, Zulfiqar Bhutta, Anju Sinha, Rajni Gaind, Tanu Singhal, Samir Saha, Abdullah Brooks, Laura B. Martin, Yeshwant Amdekar, Amar Jeet Chitkara, Mae Shieh, Ambujam Nair Kapur, Tulsi Das Chugh

    Published 2010-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Immunogenicity of self-associated aggregates and chemically cross-linked conjugates of the 42 kDa Plasmodium falciparum merozoite surface protein-1.

    Immunogenicity of self-associated aggregates and chemically cross-linked conjugates of the 42 kDa Plasmodium falciparum merozoite surface protein-1. by Feng Qian, Karine Reiter, Yanling Zhang, Richard L Shimp, Vu Nguyen, Joan A Aebig, Kelly M Rausch, Daming Zhu, Lynn Lambert, Gregory E D Mullen, Laura B Martin, Carole A Long, Louis H Miller, David L Narum

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Protein-specific immune response elicited by the Shigella sonnei 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to Shigella

    Protein-specific immune response elicited by the Shigella sonnei 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to Shigella by Arlo Z. Randall, Valentino Conti, Usman Nakakana, Xiaowu Liang, Andy A. Teng, Antonio Lorenzo Di Pasquale, Melissa Kapulu, Robert Frenck, Odile Launay, Pietro Ferruzzi, Antonella Silvia Sciré, Elisa Marchetti, Christina Obiero, Jozelyn V. Pablo, Joshua Edgar, Philip Bejon, Adam D. Shandling, Joseph J. Campo, Angela Yee, Laura B. Martin, Audino Podda, Francesca Micoli

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.

    Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909. by Christopher J A Duncan, Susanne H Sheehy, Katie J Ewer, Alexander D Douglas, Katharine A Collins, Fenella D Halstead, Sean C Elias, Patrick J Lillie, Kelly Rausch, Joan Aebig, Kazutoyo Miura, Nick J Edwards, Ian D Poulton, Angela Hunt-Cooke, David W Porter, Fiona M Thompson, Ros Rowland, Simon J Draper, Sarah C Gilbert, Michael P Fay, Carole A Long, Daming Zhu, Yimin Wu, Laura B Martin, Charles F Anderson, Alison M Lawrie, Adrian V S Hill, Ruth D Ellis

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: